BrightSpring Health Services, Inc.
BTSGNasdaq
$70.69
↑ +3.7%Jul 17 close · end-of-day
Price
1Y↑ +252.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$15.6B
Enterprise Value
$17.3B
P/E
50.5
P/S
1.1
P/B
7.9
EV/EBITDA
32.7
PEG
—
FCF Yield
2.6%
Dividend Yield
—
Revenue (TTM)
$13.6B
Net Income (TTM)
$308.3M
Free Cash Flow (TTM)
$412.1M
Gross Margin
12.2%
Operating Margin
2.7%
Net Margin
2.3%
ROE
15.6%
ROIC
8.2%
Debt / Equity
1.3
Net Cash
-$1.6B
Return 1Y
+251.7%
Company profile
We are a leading home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. We were incorporated in Delaware on July 19, 2017, as Phoenix Parent Holdings Inc., in connection with KKR Stockholder’s and Walgreen Stockholder’s acquisition of PharMerica Corporation, which was completed in December 2017. In March 2019, we acquired BrightSpring Health Holdings Corp. and its subsidiaries. We changed our name to BrightSpring Health Services, Inc. in May 2021. Our principal offices are located at 805 N. Whittington Parkway, Louisville, Kentucky.
- CEO
- Jon Rousseau
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- Kentucky
- Website
- www.brightspringhealth.com
Management & directors
- Greenwell Scott A.President, PharMerica
- Nalley Lisa ASee Remarks
- Phipps Jennifer AChief Financial Officer
- Rousseau Jon BSee Remarks
- Barnes Robert AllenPresident, Community Living
Roles derived from SEC Form 4 filings.
Earnings
BTSG Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$3.6B↑ +25.6%
Diluted EPS$0.67↑ +378.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $6.6B | $7.7B | $10.1B | $12.9B |
| Gross profit | $1.1B | $1.1B | $1.3B | $1.5B |
| Operating income | $118.9M | $58.1M | $108.0M | $295.3M |
| Net income | -$53.9M | -$154.6M | $20.5M | $189.1M |
| Diluted EPS | -$0.46 | -$1.31 | -$0.09 | $0.87 |
| Operating cash flow | -$4.7M | $210.8M | $23.8M | $490.2M |
| Free cash flow | -$74.8M | $137.3M | -$57.1M | $394.7M |
| Gross margin | 16.3% | 14.8% | 12.6% | 11.8% |
| Operating margin | 1.8% | 0.8% | 1.1% | 2.3% |
| Net margin | -0.8% | -2.0% | 0.2% | 1.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.9B | $1.9B | $2.9B | $3.1B | $3.3B | $3.6B | $3.6B |
| Gross profit | $312.2M | $323.1M | $338.7M | $338.4M | $374.9M | $392.0M | $412.5M | $482.2M |
| Operating income | $38.7M | $29.1M | $55.5M | $50.7M | $48.6M | $87.8M | $108.1M | $121.4M |
| Net income | $19.9M | -$8.2M | $54.6M | $29.5M | $28.2M | $55.8M | $75.5M | $148.8M |
| Diluted EPS | $0.10 | -$0.04 | $0.11 | $0.14 | $0.13 | $0.26 | $0.34 | $0.67 |
| Operating cash flow | -$15.2M | $27.2M | $90.6M | $101.6M | $49.1M | $107.9M | $231.6M | $122.9M |
| Free cash flow | -$39.0M | $7.2M | $75.3M | $84.0M | $24.7M | $92.2M | $193.9M | $101.4M |
| Gross margin | 11.4% | 11.1% | 18.2% | 11.8% | 11.9% | 11.8% | 11.6% | 13.3% |
| Operating margin | 1.4% | 1.0% | 3.0% | 1.8% | 1.5% | 2.6% | 3.0% | 3.4% |
| Net margin | 0.7% | -0.3% | 2.9% | 1.0% | 0.9% | 1.7% | 2.1% | 4.1% |
Company news
Jul 16, 2026
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-20 | Greenwell Scott A.· President, PharMerica | Tax withholding | 2,487 | $66.25 | $164,763.75 | filing |
| 2026-06-11 | Shah Nigam H. | Award | 4,013 | $0.00 | $0.00 | filing |
| 2026-06-05 | KKR Phoenix Aggregator L.P. | Sale | 14,669,771 | $58.45 | $857.5M | filing |
| 2026-06-05 | KKR Fund Holdings L.P. | Sale | 14,669,771 | $58.45 | $857.5M | filing |
| 2026-06-05 | ROUSSEAU JON B· See Remarks | Sale | 130,000 | $58.75 | $7.6M | filing |
| 2026-06-05 | ROUSSEAU JON B· See Remarks | Sale | 130,000 | $58.75 | $7.6M | filing |
| 2026-06-05 | Nalley Lisa A· See Remarks | Sale | 35,000 | $58.75 | $2.1M | filing |
| 2026-06-05 | Phipps Jennifer A· Chief Financial Officer | Sale | 35,000 | $58.75 | $2.1M | filing |
| 2026-06-05 | ROUSSEAU JON B· See Remarks | Option exercise | 130,000 | $6.37 | $828,100.00 | filing |
| 2026-06-05 | ROUSSEAU JON B· See Remarks | Option exercise | 130,000 | $6.37 | $828,100.00 | filing |
| 2026-06-05 | Nalley Lisa A· See Remarks | Option exercise | 35,000 | $6.37 | $222,950.00 | filing |
| 2026-06-05 | Phipps Jennifer A· Chief Financial Officer | Option exercise | 35,000 | $6.37 | $222,950.00 | filing |
| 2026-06-05 | KKR Fund Holdings L.P. | Gift | 23,263 | $0.00 | $0.00 | filing |
| 2026-06-05 | KKR Phoenix Aggregator L.P. | J | 324,608 | $0.00 | $0.00 | filing |
| 2026-06-05 | KKR Phoenix Aggregator L.P. | Gift | 36,927 | $0.00 | $0.00 | filing |
| 2026-06-05 | KKR Phoenix Aggregator L.P. | Gift | 23,263 | $0.00 | $0.00 | filing |
| 2026-06-05 | KKR Fund Holdings L.P. | J | 324,608 | $0.00 | $0.00 | filing |
| 2026-06-05 | KKR Fund Holdings L.P. | Gift | 36,927 | $0.00 | $0.00 | filing |
| 2026-05-05 | Miller Steven B | Award | 4,983 | $0.00 | $0.00 | filing |
| 2026-05-05 | KIRTLEY OLIVIA F | Award | 4,983 | $0.00 | $0.00 | filing |
| 2026-05-05 | Wicks Timothy A | Award | 4,983 | $0.00 | $0.00 | filing |
| 2026-04-25 | ROUSSEAU JON B· See Remarks | Tax withholding | 16,222 | $48.16 | $781,251.52 | filing |
| 2026-03-30 | Barnes Robert Allen· President, Community Living | Tax withholding | 6,748 | $41.54 | $280,311.92 | filing |
| 2026-03-05 | Greenwell Scott A.· President, PharMerica | Award | 20,020 | $0.00 | $0.00 | filing |
| 2026-03-05 | Nalley Lisa A· See Remarks | Award | 21,354 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.